The role of extracellular biophysical cues in modulating the Hippo-YAP pathway

키워드

참고문헌 (95)

1. Yu FX, "Hippo Pathway in Organ Size Control. Tissue Homeostasis, and Cancer", Cell, 163, pp.811~828 (2015)
2. Harvey KF, "The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis", Cell, 114, pp.457~467 (2003)
3. Jia J, "The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis", Genes Dev, 17, pp.2514~2519 (2003)
4. Justice RW, "The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation", Genes Dev, 9, pp.534~546 (1995)
5. Pantalacci S, "The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila", Nat Cell Biol, 5, pp.921~927 (2003)
6. Xu T, "Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase", Development, 121, pp.1053~1063 (1995)
7. Udan RS, "Hippo promotes proliferation arrest and apoptosis in the Salvador", Warts pathway, 2003, pp.5, 914~920
8. Wu S, "Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts", Cell, 114, pp.445~456 (2003)
9. Kango-Singh M, "Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila", Development, 129, pp.5719~5730 (2002)
10. Tapon N, "Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines", Cell, 110, pp.467~478 (2002)
11. Lai ZC, "Control of cell proliferation and apoptosis by mob as tumor suppressor, mats", Cell, 120, pp.675~685 (2005)
12. Huang J, "The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP", Cell, 122, pp.421~434 (2005)
13. Dong J, "Elucidation of a universal size-control mechanism in Drosophila and mammals", Cell, 130, pp.1120~1133 (2007)
14. Staley BK, "Hippo signaling in Drosophila: recent advances and insights", Dev Dyn, 241, pp.3~15 (2012)
15. Oh H, "In vivo regulation of Yorkie phosphorylation and localization", Development, 135, pp.1081~1088 (2008)
16. Ren F, "Hippo signaling regulates Yorkie nuclear localization and activity through 14-3-3 dependent and independent mechanisms", Dev Biol, 337, pp.303~312 (2010)
17. Mahoney WM Jr, "The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members", Biochem J, 388, pp.217~225 (2005)
18. Vassilev A, "TEAD", TEF transcription factors utilize the activation domain of YAP65, a Src, Genes Dev, pp.2001, 15[DOI]
19. Zhao B, "Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control", Genes Dev, 21, pp.2747~2761 (2007)
20. Sudol M, "Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product", Oncogene, 9, pp.2145~2152 (1994)
21. Hao Y, "Tumor suppressor LATS1 is a negative regulator of oncogene YAP", J Biol Chem, 283, pp.5496~5509 (2008)
22. Oka T, "Mst2 and Lats kinases regulate apoptotic function of Yes kinaseassociated protein (YAP)", J Biol Chem, 283, pp.27534~27546 (2008)
23. Lei QY, "TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the Hippo pathway", Mol Cell Biol, 28, pp.2426~2436 (2008)
24. Kanai F, "TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins", EMBO J, 19, pp.6778~6791 (2000)
25. Liu CY, "The Hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase", J Biol Chem, 285, pp.37159~37169 (2010)
26. Zhao B, "TEAD mediates YAPdependent gene induction and growth control", Genes Dev, 22, pp.1962~1971 (2008)
27. Zhang H, "TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition", J Biol Chem, 284, pp.13355~13362 (2009)
28. Zhu C, "The regulation and function of YAP transcription co-activator", Acta Biochim Biophys Sin (Shanghai), 47, pp.16~28 (2015)
29. Zanconato F, "YAP", TAZ at the roots of cancer, 2016, pp.29, 783~803
30. Ota M, "Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling", Development, 135, pp.4059~4069 (2008)
31. Nishioka N, "The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass", Dev Cell, 16, pp.398~410 (2009)
32. Gumbiner BM, "The Hippo-YAP signaling pathway and contact inhibition of growth", J Cell Sci, 127, pp.709~717 (2014)
33. Yang CC, "Differential regulation of the Hippo pathway by adherens junctions and apical-basal cell polarity modules", Proc Natl Acad Sci U S A, 112, pp.1785~1790 (2015)
34. Driscoll TP, "Cytoskeletal to Nuclear Strain Transfer Regulates YAP Signaling in Mesenchymal Stem Cells", Biophys J, 108, pp.2783~2793 (2015)
35. Aragona M, "A mechanical checkpoint controls multicellular growth through YAP", TAZ regulation by actin-processing factors, 2013, pp.154, 1047~1059
36. Dupont S, "Role of YAP", TAZ in mechanotransduction, 2011, pp.474, 179~183
37. Sun Y, "Hippo", YAPmediated rigidity-dependent motor neuron differentiation of human pluripotent stem cells, 2014, pp.13, 599~604
38. Wada K, "Hippo pathway regulation by cell morphology and stress fibers", Development, 138, pp.3907~3914 (2011)
39. Sansores-Garcia L, "Modulating F-actin organization induces organ growth by affecting the Hippo pathway", EMBO J, 30, pp.2325~2335 (2011)
40. Fernandez BG, "Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila", Development, 138, pp.2337~2346 (2011)
41. Ikeda S, "Aberrant actin cytoskeleton leads to accelerated proliferation of corneal epithelial cells in mice deficient for destrin (actin depolymerizing factor)", Hum Mol Genet, 12, pp.1029~1037 (2003)
42. Zhao B, "Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis", Genes Dev, 26, pp.54~68 (2012)
43. Codelia VA, "Regulation of YAP by mechanical strain through Jnk and Hippo signaling", Curr Biol, 24, pp.2012~2017 (2014)
44. Calvo F, "Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancerassociated fibroblasts", Nat Cell Biol, 15, pp.637~646 (2013)
45. Chan SW, "A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells", Cancer Res, 68, pp.2592~2598 (2008)
46. Cordenonsi M, "The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells", Cell, 147, pp.759~772 (2011)
47. Kim KM, "Shear stress induced by an interstitial level of slow flow increases the osteogenic differentiation of mesenchymal stem cells through TAZ activation", PLoS One, 9, pp.e92427~ (2014)
48. Wang KC, "Flow-dependent YAP", TAZ activities regulate endothelial phenotypes and atherosclerosis, 2016, pp.113, 11525~11530
49. Sabine A, "FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature", J Clin Invest, 125, pp.3861~3877 (2015)
50. Miller E, "Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP", Chem Biol, 19, pp.955~962 (2012)
51. Yu FX, "Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling", Cell, 150, pp.780~791 (2012)
52. Cai H, "The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells", Cell Commun Signal, 11, pp.31~ (2013)
53. Mo JS, "Regulation of the Hippo-YAP pathway by proteaseactivated receptors (PARs)", Genes Dev, 26, pp.2138~2143 (2012)
54. Lappano R, "G protein-coupled receptors: novel targets for drug discovery in cancer", Nat Rev Drug Discov, 10, pp.47~60 (2011)
55. Yu FX, "Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation", Genes Dev, 27, pp.1223~1232 (2013)
56. Zhu H, "Proton-sensing GPCR-YAP Signalling Promotes Cell Proliferation and Survival", Int J Biol Sci, 11, pp.1181~1189 (2015)
57. Zhu H, "Proton-sensing GPCR-YAP Signalling Promotes Cancer-associated Fibroblast Activation of Mesenchymal Stem Cells", Int J Biol Sci, 12, pp.389~396 (2016)
58. Zhou X, "Estrogen regulates Hippo signaling via GPER in breast cancer", J Clin Invest, 125, pp.2123~2135 (2015)
59. Feng X, "Thromboxane A2 Activates YAP", TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration, 2016, pp.291, 18947~18958
60. Wennmann DO, "The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes", Cell Death Dis, 5, pp.e1519~ (2014)
61. Chen D, "LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker", Nat Med, 18, pp.1511~1517 (2012)
62. Fan R, "Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1", Proc Natl Acad Sci U S A, 110, pp.2569~2574 (2013)
63. Azzolin L, "YAP", TAZ incorporation in the beta-catenin destruction complex orchestrates the Wnt response, 2014, pp.158, 157~170
64. Barry ER, "Restriction of intestinal stem cell expansion and the regenerative response by YAP", Nature, 493, pp.106~110 (2013)
65. Heallen T, "Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size", Science, 332, pp.458~461 (2011)
66. Rosenbluh J, "beta- Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis", Cell, 151, pp.1457~1473 (2012)
67. Varelas X, "The Hippo pathway regulates Wnt", beta-catenin signaling, 2010, pp.18, 579~591
68. Park HW, "Alternative Wnt Signaling Activates YAP", TAZ, 2015, pp.162, 780~794
69. Azzolin L, "Role of TAZ as mediator of Wnt signaling", Cell, 151, pp.1443~1456 (2012)
70. Alarcon C, "Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways", Cell, 139, pp.757~769 (2009)
71. Fujii M, "TGF-beta synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth", J Exp Med, 209, pp.479~494 (2012)
72. Varelas X, "TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal", Nat Cell Biol, 10, pp.837~848 (2008)
73. Feng X, "Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry", Cancer Cell, 25, pp.831~845 (2014)
74. Liu G, "Kaposi sarcomaassociated herpesvirus promotes tumorigenesis by modulating the Hippo pathway", Oncogene, 34, pp.3536~3546 (2015)
75. Yu FX, "Mutant Gq", 11 promote uveal melanoma tumorigenesis by activating YAP, 2014, pp.25, 822~830
76. DeRan M, "Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein", Cell Rep, 9, pp.495~503 (2014)
77. Mo JS, "Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway", Nat Cell Biol, 17, pp.500~510 (2015)
78. Wang W, "AMPK modulates Hippo pathway activity to regulate energy homeostasis", Nat Cell Biol, 17, pp.490~499 (2015)
79. Mohseni M, "A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway", Nat Cell Biol, 16, pp.108~117 (2014)
80. Nguyen HB, "LKB1 tumor suppressor regulates AMP kinase", mTORindependent cell growth and proliferation via the phosphorylation of Yap, 2013, pp.32, 4100~4109
81. Gailite I, "Differential control of Yorkie activity by LKB1", AMPK and the Hippo, Proc Natl Acad Sci U S A, pp.2015, 112[DOI]
82. Park YY, "Yes-associated protein 1 and transcriptional coactivator with PDZbinding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma", Hepatology, 63, pp.159~172 (2016)
83. Hansen CG, "The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1", Cell Res, 25, pp.1299~1313 (2015)
84. Artinian N, "Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness", J Biol Chem, 290, pp.19387~19401 (2015)
85. Sciarretta S, "mTORC2 regulates cardiac response to stress by inhibiting MST1", Cell Rep, 11, pp.125~136 (2015)
86. Liang N, "Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex", J Exp Med, 211, pp.2249~2263 (2014)
87. Parker J, "Scaling the Drosophila Wing: TOR-Dependent Target Gene Access by the Hippo Pathway Transducer Yorkie", PLoS Biol, 13, pp.e1002274~ (2015)
88. Tumaneng K, "YAP mediates crosstalk between the Hippo and PI(3)KTOR pathways by suppressing PTEN via miR-29", Nat Cell Biol, 14, pp.1322~1329 (2012)
89. Cinar B, "MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling", Cancer Res, 71, pp.4303~4313 (2011)
90. Collak FK, "Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase", Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1, 2012, pp.287, 23698~23709
91. Garcia-Martinez JM, "mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)", Biochem J, 416, pp.375~385 (2008)
92. Ikenoue T, "Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling", EMBO J, 27, pp.1919~1931 (2008)
93. Facchinetti V, "The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C", EMBO J, 27, pp.1932~1943 (2008)
94. Sorrentino G, "Metabolic control of YAP and TAZ by the mevalonate pathway", Nat Cell Biol, 16, pp.357~366 (2014)
95. Wehr MC, "Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila", Nat Cell Biol, 15, pp.61~71 (2013)

관련 논문AI추천